What Huma has learned from COVID-19
The COVID-19 pandemic has changed our world; the emotional and physical toll, uncertainty, and disruption are leaving a huge mark. Most of us have not seen this level of pressure on healthcare, businesses and communities for generations.
We have all needed to do things differently, and we will continue to do so as we face an uncertain future. But there are also reasons for hope. The speed of development has been unprecedented, with at least three new vaccines created in less than a year, and a transformation in healthcare technology enabling the same number of clinicians to care for ever more people.
At Huma, we have played our part by pioneering digital technology that not only helps in the fight against COVID-19, but allows better healthcare for all. We created virtual wards that have been approved nationally through the NHS, enabled remote clinical trials to understand the impacts of the illness and are enabling clinicians to collect real-time data from over 1 million patients.
Along the way, we've learnt three important lessons on how COVID-19 is shaping modern medicine:
1. We can successfully monitor patients remotely on a national scale
The NHS has faced a particularly tough challenge of caring for a significant number of COVID-19 patients along with people living with chronic conditions. We helped them monitor these patients remotely, doubling the number of patients they could look after¹ with 94% patient adherence*.
Before COVID-19, we were already working with the NHS to remotely monitor patients with chronic and rare conditions. We realised we could adapt this work for COVID-19 patients.
Huma’s COVID-19 Remote Patient Monitoring (RPM) technology gives real-time feedback about patients and flags any deterioration in their health. Patients use an app, pulse oximeter and digital thermometer to track vital signs and symptoms, whilst clinicians can see any changes at a glance and focus on those in need.
The technology has been so successful that a BMJ article reported that we had enabled twice as many patients to be cared for at home, with 94% patient adherence. We have been approved for use across the NHS and in hospitals and GP practices in Germany.
The RPM system is working so well, that many partners are asking to use it for other patients and other diseases that need monitoring in the community.
2. Remote clinical trials are gathering data faster whilst bringing costs down
Research has also been threatened by COVID-19. Our technology has helped keep clinical trials running by allowing them to be done remotely.
Huma and the MRC Epidemiology Unit based at the University of Cambridge are running a virtual study to understand the progression and early signs of COVID-19 infection. The study remotely monitors 12,435 participants to develop pre-symptomatic prediction models of COVID-19.
Huma is also working with Bayer, Stanford Medicine and the Stanford Center for Digital Health to run clinical trials on atrial fibrillation. The study will remotely monitor U.S. patients over six months, with the dual aim of supporting patients and paving the way for decentralised clinical trials.
Whilst a necessity during COVID-19, the ability to run clinical trials remotely greatly increases who can take part in any research - this could remove a key barrier to participation.
3. There’s a growing need for self-managed health
COVID-19’s harm has made us realise the importance of needing to understand our health better and how to control, monitor, and make positive changes in order to lower our risk of developing severe illness.
Huma worked with Johns Hopkins University to make a tool that uses digital biomarkers to help assess someone’s likelihood of being more severely affected should they contract the COVID-19. This ‘COVID-19 Severity Risk Score’ is shared with individuals via an app, and comprises a calculator that requires the individual to enter personal health data manually, in addition to certain measures collected from smartphone sensors.
The results are presented as a range, and aim to empower individuals to better understand their own health, including risk factors that influence prognosis and disease progression relating to COVID-19 and similar pandemics.
Huma’s digital solutions and their success in helping combat the COVID-19 pandemic is a testament to our mission in striving for a world where each person can live their life to the fullest.
We’re proud to be part of a wonderful team that has worked tirelessly to make a difference.
If you’d like to learn more about Huma, feel free to visit our website.
¹ The “virtual wards” supporting patients with covid-19 in the community. BMJ 2020;369:m2119 https://www.bmj.com/content/369/bmj.m2119
* During 94% of patient days, patients reported oxygen saturation and heart rate data. Data collected between 20 April - 18 August 2020 (n=274)
AI detects patients at highest risk of COVID-19 mortality
Peer-reviewed research published in Nature Scientific Reports
Atos and Huma support Symbiosis Hospital to expand care capacity
Huma’s ‘hospital at home’ technology will expand care capacity in Pune, India by up to 60%
Breaking the bias in cardiovascular disease
How digital-first care and research can address the gender bias in cardiovascular disease
Decentralized trial sees increased adherence to heart medication
A study testing if a cardiac trial could be run entirely remotely found rapid recruitment, high engagement and that patients with low baseline increased their medication adherence from 85% to 96%.
Digital support against Covid-19 in Germany
Press release: German states focus on patient care via app
Driving Patient Safety with Digital Technology
Patient safety may be paramount across healthcare, but we are a long way from ‘first, do no harm’. The World Health Organisation (WHO) reports that medication errors cause US$ 42 billion of global total health expenditure worldwide, 50% of the overall preventable harm in medical care.
FT 1000: Huma named Europe's fastest growing healthcare company
Press release: Huma listed in the Top 25 for all sectors
Fierce biotech webinar
Taking the "clinic" out of clinical trials and healthcare: Bridging research and care with digital tools
Fixing the foundations: building a solid evidence base for digital health
Our Global Clinical Directors Arrash Yassaee and Peter Kirpalani-Collins explain the importance of clinical rigour and evidence generation in digital health and how we’re doing things differently here at Huma.
HSJ Value Awards 2021
Huma has been shortlisted as a finalist for the HSJ Value Awards 2021.
How Huma technology can reduce burnout on virtual wards
Expectations are high when you hold people’s lives in your hands, so it is little wonder that physicians report emotional exhaustion and feeling overextended, plus a feeling of depersonalization.
How can digital solutions empower and support heart failure patients?
We launched a 12-week remote patient monitoring pilot with Cwm Taf and Betsi Cadwaladr University Health Boards
How decentralized and hybrid trials can drive efficiencies beyond the pandemic
Huma’s Nico O'Kuinghttons discusses how we can drive more efficient decentralized and hybrid clinical trials post-pandemic
How our digital CVD risk model can help reduce avoidable deaths
Our research was published in European Heart Journal Digital Health (EHJ-DH)
How to accelerate digital adoption across the UK healthcare system
We have only seen the tip of the iceberg when it comes to digital health. There is so much more that can be achieved with the adoption of remote patient monitoring - but how can we accelerate it?
How to design virtual wards: 5 tips to set you up for success
Our clinical deployment lead, Dr Terry Deeny shares his top tips for designing successful virtual ward programmes based on Huma’s experience supporting the NHS.
How we help tackle cardiac surgical waiting lists
We worked with Royal Brompton and Harefield hospitals to remotely monitor and prioritise deteriorating patients.
Huma Appoints Kaushik Gune as Head of U.S. Healthcare Business to Promote Adoption of Digital Health Solutions
Huma has appointed Kaushik Gune as the company’s new U.S. Head of Healthcare
Huma acquires iPLATO Healthcare to advance digital-first delivery of care
The two companies will combine their expertise to provide remote patient monitoring for NHS patients
Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care
Huma acquires AstraZeneca’s digital health platform AMAZE™ and AstraZeneca becomes a shareholder of Huma
Huma and RARE-X partner to accelerate research
Press release: RARE-X’s federated data platform will pair with Huma’s DCT platform to accelerate research
Huma and Tamer bring digital ‘hospital at home’ platform to the Kingdom of Saudi Arabia
Tamer will bring Huma’s ‘hospitals at home’ technology to the Kingdom of Saudi Arabia to tackle diabetes and cardiovascular disease.
Huma announces US expansion
Press release: Experienced industry leaders create founding US Huma team
Huma appoints Shahram Sharif as Chief Business Officer - Medtech to accelerate digital-first use in the medtech industry
Sharif joins Huma to lead business development activities for digital companion app product
Huma calls for safeguarding of scientific collaboration
CEO & Founder Dan Vahdat speaks at World Economic Forum event in Davos.
Huma collaborates with Bayer to advance precision treatment for lung cancer
Medical technology powered using artificial intelligence
Huma finds way to measure breathing rate using entry-level smartphone gyroscopes
Huma researchers have verified a way to measure breathing rate using the gyroscopes in entry-level smartphones.
Huma joins forces with independent healthcare provider to launch virtual ward service for the NHS
Huma and Xyla Elective Care will work together to deliver tech-enabled virtual wards for the NHS
Huma raises $130 million financing to scale its digital health platform for better care and research
Leading names in health and technology fund expansion
Huma wins prestigious Prix Galien USA 2021 award
Huma’s remote patient monitoring technology is awarded ‘pharma’s Nobel Prize’
Huma wins ‘best of the best’ Prix Galien International 2022 award
Huma has won the Prix Galien International 2022 ‘best of the best digital health product’ award for the impact of its remote patient monitoring platform across healthcare and research.
Huma’s collaborative Covid-19 project wins HSJ Value Award
Our teams enabled better patient care and doubled clinical capacity with our hospital at home technology.
Huma’s peer-reviewed research links bedtime with heart health
Our peer-reviewed research explored the link between time of sleep and risk of cardiovascular disease in over 88,000 people
Increasing clinical trial success rates with adaptive technology
Overall, adaptive trials are more efficient, take less time to complete, and need fewer participants. By allowing for pre-planned modifications to a trial’s design after it has begun, adaptive trials make much better use of resources and money.
Keeping patients safe at home with virtual wards
Digital health has an important role to play in reducing patient harm and improving safety. This blog explores some of the key challenges, insights and learnings that enable safer patient care when using digital technology.
Key themes from this year's MedTech Conference 2022
MedTech Conference 2022, in Boston, one of MedTech’s leading annual events, has wrapped up, and we caught up with our Huma MedTech team to get the low down on all the industry buzz from this year's show.
Mediclinic Middle East launches Mediclinic at Home
A new remote care monitoring system for patients suffering from chronic conditions
Microsoft White Paper: Trends Shaping the Future of Clinical Trials
Microsoft explores the future of clinical trials and how decentralization, using tools like Huma’s, could be the key to shaping their future.
NHS Long Term Plan Webinar Series
How digital technology is helping to battle the growing waiting list backlog
Pharma and digital health must join forces for patients
Dan Vahdat, CEO and Founder of Huma, discusses how we are working with pharma partners to improve clinical outcomes through digital health solutions.
Powering COVID-19 virtual wards for better patient outcomes
Researchers have found that COVID-19 mortality rates were up to four times lower and hospital stays decreased by forty percent with Huma’s technology¹.
Remote patient monitoring pilot shortlisted for two prestigious HSJ Awards
The project has been nominated in the ‘Digitising Patient Care’ category at the HSJ Awards and ‘Virtual or Remote Care Initiative of the Year’ category at the HSJ Patient Safety Awards.
Smith+Nephew partner with Huma
Press release: Smith+Nephew and Huma develop RPM app to assist the restart of UK orthopaedic surgery
Taking the ‘clinic’ out of clinical trials
Bridging research and care with digital tools
Ten highlights from 2021, our 10th anniversary year
How we’re helping ~two million users across our platforms and people around the world live longer, fuller lives
Three ways that digital-first care can improve patient safety
During the COVID-19 pandemic the public were under quarantine orders preventing many patients from seeking care. A study on remote-patient monitoring showed that digital-first care provided a safe and effective option for patients with COVID-19.
Virtual Wards vital to help NHS tackle ‘substantial’ pressures
Huma welcome the Government’s announcement to accelerate the roll out of digital technology to provide an extra 2,500 virtual ward ‘beds’¹.
Webinar: Advancing digital-first delivery of care
Huma and iPLATO (myGP) hosted a joint webinar on how we can bring digital-first care to patients at scale
Webinar: Bridging the digital divide for improved patient diversity
Huma joined leading industry experts for a Reuters Events webinar on fostering diversity in decentralized and hybrid clinical trials
Webinar: Bringing the hospital home via digital virtual wards
Watch our webinar with leaders from the NHS and the AHSH Network.
Webinar: Empowering patients and relieving pressure on the NHS
Learn how Huma’s technology helps clinicians improve outcomes for heart failure patients and identify deteriorating cardiac surgery patients with almost 90% specificity
What Huma has learned from COVID-19
Three important lessons on how COVID-19 is shaping modern medicine
Why we acquired iPLATO (myGP)
Huma & iPLATO (myGP) join to create new possibilities in healthcare and research
World Patient Safety Day: supporting medicine safety with digital tools
For World Patient Safety Day in 2022, our Global Clinical Director Peter Kirpalani-Collins explains how digital healthcare tools can help keep patients safe by monitoring their symptoms and medication use.